People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| La Jolla Pharmaceutical Co | — | Pharmaceuticals | Series B | $22.9M | $603.8M | 2011 |
STEPHEN M. MARTIN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside STEPHEN M. MARTIN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| SAIID ZARRABIAN | 1 | 3 |
| Bertrand C. Liang | 1 | 3 |
| GEORGE TIDMARSH | 1 | 2 |
| DEIRDRE Y. GILLESPIE | 1 | 1 |
| ROBERT A. FILDES | 1 | 1 |
| CHESTER ZYGMONT, III | 1 | 1 |
| GAIL A. SLOAN | 1 | 1 |
| RUIZ STACEY | 1 | 1 |
| JAMES ROLKE | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.